NDC 55513-206-01
MVASI 100 mg/4mL
bevacizumab-awwb · INJECTION, SOLUTION
MVASI is a injection, solution containing bevacizumab-awwb at a strength of 100 mg/4mL. Manufactured by Amgen, Inc.
Key Facts
- Brand Name
- MVASI
- Generic Name
- bevacizumab-awwb
- NDC Code (Package)
55513-206-01- NDC Code (Product)
55513-206- Manufacturer
- Amgen, Inc
- Strength
- 100 mg/4mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761028
- Drug Class
- Vascular Endothelial Growth Factor Inhibitor [EPC]
- Marketing Start
- 06/01/2018
Recall History
No Recall HistoryView Full Drug Page
MVASI — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.